Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
156 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Algemeen Ziekenhuis Klina
Antwerp, Belgium
Not, yet, recruiting - Grand Hôpital de Charleroi - Site Notre-Dame
Charleroi, Belgium
Not, yet, recruiting - Az Groeningen
Kortrijk, Belgium
Not, yet, recruiting - Jessa Ziekenhuis - Campus Virga Jesse
Limbourg, Belgium
Not, yet, recruiting - Chu Ucl Namur - Site Sainte-Elisabeth
Namur, Belgium
Not, yet, recruiting
- Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
Recruiting - Xiangya Hospital Central South University
Changsha, Hunan, China
Recruiting - the Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Recruiting - the First Hospital of China Medical University
Shenyang, Liaoning, China
Recruiting - Shandong Cancer Hospital & Institute
Jinan, Shandong, China
Jinming Yu, MD, PhD,Recruiting - Anyang Tumor Hospital
Anyang, China
Recruiting - Beijing Cancer Hospital
Beijing, China
Not, yet, recruiting - Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
Recruiting - Jilin Cancer Hospital
Changchun, China
Recruiting - Hunan Cancer Hospital
Changsha, China
Recruiting - Sichuan Cancer Hospital
Chengdu, China
Not, yet, recruiting - Chongqing University Cancer Hospital
Chongqing, China
Recruiting - Peking University Shenzhen Hospital
Guangdong, China
Not, yet, recruiting - Sun Yat-Sen University Cancer Center
Guangzhou, China
Recruiting - No. 1 Bandong Road, Gongshu District, Hangzhou
Hangzhou, China
Recruiting - the Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China
Recruiting - the First Affiliated Hospital of Ustc
Hefei, China
Recruiting - Henan Cancer Hospital
Henan, China
Not, yet, recruiting - Affiliated Hospital of Jining Medical University
Jining, China
Not, yet, recruiting - the First Affiliated Hospital of Nanchang University
Nanchang, China
Recruiting - the Second Affiliated Hospital of Nanchang University
Nanchang, China
Recruiting - the Affiliated Hospital of Qingdao University
Qingdao, China
Not, yet, recruiting - Fudan University Shanghai Cancer Center
Shanghai, China
Not, yet, recruiting - Liaoning Cancer Hospital
Shenyang, China
Not, yet, recruiting - Shanxi Cancer Hospital
Taiyuan, China
Recruiting - Taizhou Hospital of Zhejiang Province
Taizhou, China
Not, yet, recruiting - Tianjin Medical University Cancer Institute & Hospital
Tianjin, China
Recruiting - Hubei Cancer Hospital (hubei Cancer Research Institute)
Wuhan, China
Recruiting - Zhongnan Hospital of Wuhan University
Wuhan, China
Recruiting - the First Affiliated Hospital of Xiamen University
Xiamen, China
Not, yet, recruiting - General Hospital of Ningxia Medical University
Yinchuan, China
Recruiting
- Centre Hospitalier Universitaire D Angers
Angers, France
Not, yet, recruiting - Institut Bergonie
Bordeaux, France
Not, yet, recruiting - Centre Hospitalier Intercommunal de Créteil
Créteil, France
Not, yet, recruiting - Chu de Grenoble
Grenoble, France
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2023
- Primary completion
- 31 Jul 2027
- Completion
- 31 Jul 2029
- Last update posted
- 21 Jun 2024
- Registered enrollment
- 756
- Registry id
- NCT06095583
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.